Exhibit 99.1
For Immediate Release:

          COMPETITIVE TECHNOLOGIES SELLS SECOND PORTION
                      OF MATERNA CASE AWARD

Fairfield, CT - (November 3, 2003) - Competitive Technologies,
Inc. (AMEX: CTT) announced today that the company successfully
negotiated a non-recourse agreement with LawFinance Group, Inc.
(LFG) to sell a second portion of CTT's expected award in the
patent infringement judgment against Wyeth's (NYSE: WYE) American
Cyanamid Co. unit.  CTT received $900,000 from LFG in return for
assigning $1,125,000 of litigation proceeds of the originally
anticipated award of nearly $6 million.

"We pursued these opportunities to sell portions of our interest
in the Materna judgment prior to final resolution to strengthen
our working capital and implement our strategic plan of
technology commercialization and licensing programs," said John
B. Nano, CTT's President and CEO.  "The fact that LFG monetized
an additional portion of the potential award demonstrates that
third party experts continue to expect a favorable outcome for
CTT."

On September 3, 2003, the US Court of Appeals for the Federal
Circuit affirmed the August 13, 2002 decision of US Senior
District Court Judge John Kane of the US District Court for the
District of Colorado for a $54 million patent infringement
judgment for fraud and unjust enrichment against Wyeth.  CTT
anticipates that the courts will continue to find in its favor in
this 10-year-old case.  The company expects its share of the
litigation award to be approximately $6 million, 18.2% after
attorney fees, of the net proceeds recovered from Wyeth.  CTT
expects to net approximately $5.1 million including the $1.5
million already received from LFG.

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, is a full service
technology transfer and licensing provider focused on the
technology needs of its customers and transforming those
requirements into commercially viable solutions.  CTT is a global
leader in identifying, developing and commercializing innovative
technologies in life, digital, nano, and physical sciences
developed by universities, companies and inventors.  The global
market for technology transfer services is estimated at $150
billion annually.  CTT maximizes the value of intellectual assets
for the benefit of its customers, clients and shareholders. Visit
CTT's website:  http://www.competitivetech.net

Statements about the Company's future expectations, including
development and regulatory plans, and all other statements in
this document other than historical facts are "forward-looking
statements" within the meaning of applicable Federal Securities
Laws and are not guarantees of future performance.  These
statements involve risks and uncertainties, including those set
forth in Item 1 of the Company's most recent Form 10-K and in
CTT's other filings with the SEC, and are subject to change at
any time.  The Company's actual results could differ materially
from these forward-looking statements.  The Company undertakes no
obligation to update publicly any forward-looking statement.

Direct inquiries to:
Johnnie D. Johnson, Strategic IR, Inc.
E-mail: jdjohnson@strategic-ir.com
Tel. (212) 754-6565;
Fax (212) 754-4333
E-mail: ctt@competitivetech.net